After 6-month wait, BioNTech announces Sobi CEO will take on top job at mRNA company Read more →

Editor’s Corner: Why an AstraZeneca-Bristol Myers Squibb merger is a bad idea Read more →

Novo Nordisk left praying to Artemis and Hermes to salvage CKD program after phase 3 fail Read more →